Karkinos Healthcare introduces CerviRaksha against cervical cancer
06 June 2022 | News
First WHO-approved HPV test in India that diagnoses a full range of HPVuman Papilloma Viruses
Image Credit: Shutterstock
Karkinos Healthcare has introduced CerviRaksha, a first-of-its-kind clinically validated HPV test, which is pre-qualified by the World Health Organisation (WHO) and approved by the Food and Drug Administration, USA (FDA) and was also granted the CE mark meeting European Health Standards.
CerviRaksha has been introduced in partnership with Karkinos’ network of hospitals, doctors, and corporates. And for the first time in HPV testing, sample collection at home is made possible to encourage more women to participate in this screening.
